Literature DB >> 10514119

Determinants of Helicobacter pylori seroprevalence among Italian blood donors.

A Russo1, M Eboli, P Pizzetti, G Di Felice, F Ravagnani, P Spinelli, A M Hotz, P Notti, G Maconi, S Franceschi, D Ferrari, L Bertario.   

Abstract

BACKGROUND/AIM: Helicobacter pylori is a worldwide infection. It is estimated that approximately 50% of the general population is affected, but this percentage varies considerably between countries. To investigate the prevalence of H. pylori infection, a cross-sectional epidemiological study, based on the serological determination of the IgG antibodies against H. pylori, was carried out in healthy Italian blood donors by using a commercially available kit.
METHODS: From March 1995 to March 1997, a total of 2598 consecutive volunteer blood donors were tested for the presence of antibodies against H. pylori. All patients answered a detailed questionnaire which collected sociodemographic characteristics, and smoking, alcohol drinking and dietary habits. Test-positive subjects with gastrointestinal symptoms underwent endoscopy, with biopsies taken for histological diagnosis.
RESULTS: The global prevalence of H. pylori infection in our study was 1161/2598 (45%). It was directly correlated with age (67% in subjects aged > or = 50 years). The prevalence of H. pylori infection was higher in men (46.4%) than women (38.4%), and more frequent in patients with a low educational level, in the lower quintile of height and in the upper quintile of body mass index (BMI). No significant association with smoking and alcohol drinking was found. Inverse associations were found with elevated consumption of milk (chi-square for trend 5.49, P < 0.05), but not other examined food groups. Multivariate analysis selected sex, age, BMI and educational level as the variables independently related to H. pylori infection.
CONCLUSION: This study confirms relatively high prevalence of H. pylori seropositivity among Italian healthy adults and points to sex, age, BMI and sociocultural class as persisting determinant features of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514119     DOI: 10.1097/00042737-199908000-00010

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 2.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

3.  Seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with or without coronary stenosis.

Authors:  C Stöllberger; G Mölzer; J Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

4.  Follow-up of intestinal metaplasia in the stomach: When, how and why.

Authors:  Angelo Zullo; Cesare Hassan; Adriana Romiti; Michela Giusto; Carmine Guerriero; Roberto Lorenzetti; Salvatore Ma Campo; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

5.  Neighborhood socio-economic characteristics, African ancestry, and Helicobacter pylori sero-prevalence.

Authors:  Meira Epplein; Sarah S Cohen; Jennifer S Sonderman; Wei Zheng; Scott M Williams; William J Blot; Lisa B Signorello
Journal:  Cancer Causes Control       Date:  2012-04-21       Impact factor: 2.506

6.  Seroepidemiology of Helicobacter pylori infection in hellenic navy recruits.

Authors:  L D Kyriazanos; L Ilias; V Gizaris; P Hountis; V Georgaklis; A Dafnopoulou; K Datsakis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?

Authors:  Paolo A Tomasi; Maria P Dore; Giuseppe Fanciulli; Franca Sanciu; Giuseppe Realdi; Giuseppe Delitala
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

8.  Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura.

Authors:  Ravinder Naik Noonavath; Chandrasekharan Padma Lakshmi; Tarun Kumar Dutta; Vikram Kate
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

9.  Unexpected decrease with age of Helicobacter pylori seroprevalence among Swedish blood donors.

Authors:  M Sörberg; O Nyrén; M Granström
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura.

Authors:  Hee Sang Tag; Ho Sup Lee; Su-Hyeon Jung; Bu-Kyung Kim; Sung-Bin Kim; Aeran Lee; Jin Soo Lee; Seong Hoon Shin; Yang Soo Kim
Journal:  Korean J Hematol       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.